Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$193.9M
5 rounds on record
Latest round
$50M
Venture round · Oct 2025 · 11 mo ago
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 21, 2025 Raised a round Venture round $50M · SEC Form D Nov 20, 2023 Raised a round Venture round $45M · SEC Form D Apr 6, 2022 Raised a round Venture round $59.3M · SEC Form D May 3, 2021 Raised a round Venture round $31.9M · SEC Form D Sep 13, 2019 Raised a round Venture round $7.7M · SEC Form D 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 $50M — SEC Form D
Venture round Nov 2023 $45M — SEC Form D
Venture round Apr 2022 $59.3M — SEC Form D
Venture round May 2021 $31.9M — SEC Form D
Venture round Sep 2019 $7.7M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Alto Neuroscience, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Adam SavitzExecutive OfficerSEC Form D
Amit EtkinExecutive Officer, DirectorSEC Form D
Nicholas SmithExecutive OfficerSEC Form D
Michael HanleyExecutive OfficerSEC Form D
Similar startupsby what they do, their industry and backers
NeuraLight51-200 employees
Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.
NGM BioVenture round $142M · 2 yr ago • Founded 2024 • 501-1000 employees
Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.
Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
Boltz14 roles
Build better molecules with frontier AI models. With AI, we help every scientist reshape biology.
NudgeFounded 2024 • 201-500 employees • 18 roles
Our Mission, Technology, and Approach April 7, 2025 At Nudge, our mission is to develop the best technology for interfacing with the brain…
CoSyne Therapeutics is a vertically integrated AI drug discovery company aiming to bring speed to precision medicine through polymathic AI…

Overview

We leverage the biology of individuals’ brains to develop personalized and highly effective medicines, helping patients get better faster.

News

Press release Nasdaq 7 months ago
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
Alto Neuroscience, Inc., a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the completion of patient enrollment in its Phase 2 proof-of-concept clinical trial
Read more
Report
News YahooFinance 10 months ago
Is Alto Neuroscience, Inc. (ANRO) Outperforming Other Medical Stocks This Year?
Here is how Alto Neuroscience, Inc. (ANRO) and Editas Medicine (EDIT) have performed compared to their sector so far this year.
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Adam Savitz
Executive Officer
Amit Etkin
Executive Officer, Director
Nicholas Smith
Executive Officer
Michael Hanley
Executive Officer
Michael Liang
Director
Christopher Cox
Director
Po Yu Jeff Chen
Director
Andrew Dreyfus
Director
Aaron Weaver
Director
Chris Dimitropoulos
Director
Gwill York
Director
Husseini Manji
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Los Altos United States
HQ
Mountain View United States
Regional office
Interested in joining the Alto team?Visit our Careers page to see our available opportunities.
650 Castro Street, Suite 450, Mountain View, CA 94041
company site

Financials

Total raised
$193.9M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $50M Details
Venture - Series Unknown 2023 $45M Details
Venture - Series Unknown 2022 $59.3M Details
Venture - Series Unknown 2021 $31.9M Details
Venture - Series Unknown 2019 $7.7M Details